NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 05/05/2026 16:00
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,828.89 mln
Float19.34 mln
Earnings Date05/08/2026
EPS
3.32
Solid
P / E
25.49
Elevated
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-2.74
Likely reliable
Relative Strength
82
/ 100
Strongly outperforming
Debt / Equity
1.14
Elevated leverage
Business Description
ANI Pharmaceuticals is a U.S.-based drug maker that produces and sells a wide range of prescription medicines, including specialty branded treatments and lower-cost generic alternatives. Its product lineup spans injections, capsules, gels, creams, and liquids, with several offerings targeting niche medical conditions. The company supplies healthcare distributors, pharmacies, hospitals, and purchasing groups across the country and in select international markets. Founded in 2001 and based in Baudette, Minnesota, ANI has grown into a diversified player in the pharmaceutical industry.
